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To confirm our previous observations on the effectiveness of long term treatment with Zn on Long–Evans Cinnamon (LEC) rats, we
extended these studies determining the effects of Zn on trace elements, metallothionein (MT) concentrations and immunolocalization, and on
the levels of both MT-1 and MT-2 mRNAs in the LEC rat kidneys. We also localized the renal cells that had chromatin condensation and
nuclear fragmentation typical of apoptosis. The results demonstrate that the amount of Zn increased in the treated rats with respect to both
untreated and basal rats. In the treated rats the amount of Cu and Fe was similar to that of the basal rats. MT concentrations did not change
either with or without Zn treatment, but were higher than the basal group. However, if we consider the percentage of oxidized MT (MTox),
we note that Zn treatment is very effective in reducing this value. MTox is not able to bind metals, so it does not perform a ‘‘scavenger’’
function. Moreover, quantification of mRNA indicates that the MT-1 isoform was significantly higher than the MT-2 isoform following Zn
treatment. Untreated group sections showed a confocal fluorescent signal that highlighted the irregular nuclei and small apoptotic bodies. The
intensity and quantity of fluorescence decreased in the treated group sections. These findings suggest that, in LEC rats, Zn may contribute to
cytoprotection through the regulation of MT expression which may provide a cellular defence strategy in response to DNA damage.
D 2004 Elsevier B.V. All rights reserved.Keywords: Metallothionein; Apoptosis; LEC rat1. Introduction
Long–Evans Cinnamon (LEC) rats are an established
animal model for Wilson’s disease, a hereditary disease
caused by a disorder of copper (Cu) metabolism. These
animals have a mutation in the gene homologous to the
human Wilson’s disease and show many features of the
disease such as elevated hepatic Cu levels, reduced biliary
Cu excretion, hemolysis, ceruloplasmin deficiency and
increased hepatic iron (Fe) levels [1]. LEC rats also show
increased Cu levels in the kidneys, which is considered to
result from the release of hepatic Cu from severely damaged
hepatocytes. Almost half of Wilson’s disease patients de-
velop renal dysfunction [2], but sufficient information is not
yet available on the renal dysfunctions in Wilson’s disease.
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that of cadmium-induced renal dysfunction: Cu accumulates
in the liver mostly in the chemical form of Cu-metallothio-
nein (MT). In this case, MT is working as the reducing
agent, forming disulfide bonds (MTox), to reduce cupric to
cuprous ions in the Fenton reaction [4]. Once the Cu
accumulation in the liver exceeds its ability to induce
sufficient MT for Cu detoxification, the cupric ions (Cu+)
induces hepatic dysfunction, and a large amount of Cu-MT
accumulated in the liver is then released into the blood.
Plasma Cu-MT passes readily through the glomeruli into the
tubular lumen because of its smaller molecular weight, and
then directly injures the brush border membrane of the renal
proximal tubular cells, where it is reabsorbed. The Cu-MT
which induces renal dysfunction is of hepatic origin and not
of renal origin. In contrast to the role of MT in the liver, the
absorbed MT in the kidneys is toxic because of the free
heavy metal ions that may be released from the MT by
lysosomal degradation and/or by oxidation in the proximal
convoluted tubules system [5]. It is also important to point
out that Cu bound to MT is present as long as cells retain the
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and Zn within cells. In this case, Cu,Zn-MT functions as an
anti-oxidant as long as excess Cu is reduced and sequestered
by MT by replacing Zn. However, when Cu accumulates to
levels that exceed the capacity of a cell to synthesize
sufficient MT, the metal liberated from oxidized-MT
(MTox) works as a catalyst in the Fenton reaction producing
hydroxyl radicals. MTox is not able to bind metals, so it
does not perform a ‘‘scavenger’’ function. For this reason,
we believe that the MTox content is an important parameter
in evaluating the cytotoxicity of Cu in LEC rats. It has been
suggested that free metal ions such as Cu and Fe are
involved in the production of free radicals, which play an
important role in the regulation and induction of the
apoptotic process.
Apoptosis or programmed cell death can be regarded as a
cellular response to DNA damage by free radicals and is
distinct from necrotic cell death both in morphology and in
mechanism [6,7]. Activation of endogenous endonuclease
resulting in oligonucleosomal DNA cleavage is the bio-
chemical basis of apoptosis [8], which represents a critical
control mechanism in the morphogenesis and normal cell
turnover of adult tissue [9]. A number of substances that
increase tissue MT levels can affect the apoptotic process in
certain cells [10]. In Bedlington Terriers (which accumulate
Cu) Cu is sequestered in the nucleus with increased apo-
ptosis. Therefore, nuclear Cu localization is correlated with
apoptotic cell death [11]. MT is a stress-responsive factor
that can regulate apoptotic engagement. MT-I and -II are
mainly involved in the protection against metal toxicities,
oxidative stress, and apoptosis [12]. MT genes possess both
metal- and glucocorticoid-responsive promoters [13,14]
which are responsible for the induction of MT genes by
metals and glucocorticoids. Moreover, cytokines have been
shown to be important regulators of MT expression in both
in vivo and in vitro studies [15,16]. In particular, IL-1 and
IL-6, which are considered important regulators of brain
MT-I and -II, mediate MT-I and -II induction after immu-
nological insults and during neurodegenerative process
[17,18]. However, in some circumstance there is evidence
of post-transcriptional control of MT gene expression.
Inhibition of protein synthesis stabilizes MT mRNA [19],
and the MT mRNA half-life depends specifically on the
inducing metal [20], thereby suggesting that there is regu-
lation of MT mRNA turnover.
Therapy for Wilson’s disease is based on administration
of Cu chelators or competitors such as Zn [21,22].
We have previously reported that Zn has antioxidant
properties in relation to MT gene expression and apoptotic
processes [23] and maintains the antioxidant enzymes
activities, GSH content and other serum biochemical param-
eters at basal levels [24].
In this paper we report the effect of 60-day treatment
with zinc acetate by gavage in LEC rat kidneys on both
MT and MTox and trace elements concentrations. We
also determined the levels of both MT-I and MT-IImRNAs isoforms, which are translated during MT induc-
tion and the distribution of MTs. Finally, we describe the
presence of apoptotic cells using an immunocytochemical
method.2. Materials and methods
2.1. Animals and treatment
Thirty male LEC rats (35 days old, 90 g body wt) from
Charles River Japan (Tokyo, Japan) were used for the study.
They were kept on a standard laboratory diet (Morini MIL
GLP diets) containing 11.7 mg Cu/kg and 67.5 mg Zn/kg
and deionised water. They were housed in comfortable
cages at 20 jC with a 12-h light–dark cycle. Zn acetate
supplement was dissolved in 2% glucose solution in dis-
tilled water.
We divided the 30 rats as follows: 13 rats received an
oral dose of Zn acetate 50 mg/ml daily by gavage for 60
days (treated group); 13 rats received an oral dose of
glucose solution 0.02 mg/ml daily by gavage for 60 days
(untreated group); 4 rats received no treatment and they
were sacrificed 35 days after birth (basal group).
Rats were sacrificed under diethyl ether and the
kidneys were quickly removed, washed in saline solution,
frozen with liquid nitrogen and stored at  80 jC for no
longer than 36 h before being used. A portion of the
tissue was also fixed with 10% formalin in PBS (0.01 M
phosphate buffered saline, pH 7.4) for 24 h at 4 jC and
embedded in paraplast for the immunohistochemical and
immunocytochemical analyses. The remainder of the liver
was used for mRNA analysis, MT and trace element
determination.
All procedures were carried out on laboratory rats in
accordance with the regulations of the National Institute’s
Health Guide for the Care and Use of Laboratory Animals.
2.2. Determination of trace elements and MT contents
A part of the renal tissue was homogenized in 4 volumes
of 20 mM Tris–HCl buffer, pH 8.6, supplemented with
0.006 mM leupeptine, 0.5 mM phenylmethylsulfonylfluor-
ide (PMSF) as antiproteolytic agents, and 0.01% h-mercap-
toethanol as reducing agent. Aliquots of homogenate (125
Al) were digested in Teflon vessels with 0.5-ml nitric acid
AristaR in a microwave CEM mod. MDS-2000. Concen-
trations of Cu, Zn and Fe were determined by atomic
absorption spectrophotometry with an air-acetylene flame
(Perkin-Elmer mod. 4000). Other 125-Al aliquots were dried
at 110 jC so that the metal contents could be referred to as g
dry weight.
The remaining homogenate was centrifuged at 4 jC at
50400 g for 50 min, and the resulting supernatant was
used for MT quantification using the silver saturation
method [25]. The MT amounts in the supernatant were
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the Lowry method [26].
The reversal of metal ion loss from MT was attempted in
accordance with a previous report [27], with some modifi-
cations. Part of the supernatant was incubated in anaerobic
conditions (N2) for 15 min with 10 mmol/l 2-mercaptoetha-
nol, and then incubated with 6 mmol/l ZnCl2 for 2 h to
reconstitute Zn-MT. The MTox content was determined
from the difference between the values obtained by the
reduction of oxidized MT and those obtained using the
silver saturation method.
2.3. RNA isolation and Northern blot analysis
Total RNAwas isolated from the frozen LEC rat kidneys
by using Trizol reagent (Life Technologies, Gaithesburg,
MD, USA). The concentration and purity of the samples
were analysed spectrophotometrically by the A260/A280 ab-
sorbance ratio and confirmed by ethidium bromide staining.
Ten-microgram portions of total RNA were fractioned by
electrophoresis on 1.0% formaldehyde agarose gels, and
transferred to nylon membranes. The oligonucleotides used
as transcript specific probes for rat MT-1 and MT-2 were
carried out in accordance with a previous report [28]. The
probes were labelled with [g-32P]dATP using T4 kinase
(Amersham International) at 37 jC for 30 min and the
reaction was stopped by the addition of 0.5 M EDTA. The
membranes were prehybridized for at least 6 h at 42 jC and
sequentially hybridized for 16 h at the same temperature
using the solution suggested by Church and Gilbert [29],
and washed three times in 0.1 M sodium phosphate buffer
(pH 7.0) and 1% SDS for 10 min at 42 jC. The amount of
RNA loaded per lane was normalized by hybridization with
a 18S rRNA specific oligonucleotide probe [30]. Hybrid-
ization signals were detected and quantified by exposure to
a Packard Instant Imager A2024. All blots were also
exposed to X-ray film.
2.4. Immunofluorescence localization of apoptotic cells
After deparaffinization and rehydration, the renal sec-
tions were processed for an immunoassay for single-strand
DNA (ssDNA) in apoptotic cells.
The slides were incubated with PBS containing 20 Ag/
ml proteinase K for 20 min at room temperature and then
washed in deionised water. The slides were transferred into
a coplin jar containing 50% formamide preheated in a
water bath to 56–60 jC for 20 min. After heating, the
slides were washed in ice-cold PBS for 5 min and incu-
bated for 45 min at room temperature with Mab F7-26
mouse anti-single-stranded DNA (1:10) monoclonal anti-
body (Chemicon International, Inc. USA, code MAB
3299). The specimens were then washed in PBS and
incubated with fluorescein-conjugated anti-mouse IgM
(1:50) for 30 min at room temperature (Chemicon Interna-
tional, code AP127F). Nuclei were counterstained byincubation with 0.5 Ag/ml propidium iodide in antifade
(phosphate balance salt solution containing 1% p-fenilen-
diamino-dietrocloruro) for 5 min, then washed in PBS.
After dehydration and clearing, the sections were mounted
on DPX mountant and examined using a BioRad Radiance
2000 laser scanning confocal system (BioRad; Milan,
Italy). Images of renal sections were collected using a
 63 oil immersion objective.
In a previous paper [23], labelling of 3V-hydroxyl ends
in DNA by TUNEL was performed to compare the
sensitivity of this technique with Mab against ssDNA.
The results suggested that formamide-induced DNA dena-
turation in the apoptotic cells was not influenced by DNA
breaks but reflects changes in DNA stability induced by
specific changes in condensed chromatin, such as damage
to the DNA–histone interaction. The specificity and the
high sensitivity of this immunocytochemical analysis lead
us to adopt this method to detect apoptotic cells in renal
tissue.
2.5. Immunohistochemical localization of MTs
Immunohistochemical procedures were carried out as
previously reported [31].
After deparaffinization and rehydration, all sections
were washed in TPBS (phosphate balance salt solution
containing 0.5% Triton X-100) for 10 min at room tem-
perature. The specimens were then placed in 0.3% H2O2–
99% methanol for 30 min at room temperature and
subsequently incubated for 1 h with the primary mouse
anti-MT monoclonal antibody. This antibody has been
characterized by Jasani and Elmes [32] and was applied
at 1:10 dilution. Immunoreactions were revealed after
incubation for 30 min with biotinylated goat anti-mouse
IgG secondary antibody, for 15 min with peroxidase-
conjugated streptavidin and for 2 min with DAB sub-
strate-chromogen solution, using the Histostaink-Plus
Kit (Zymed Laboratories, San Francisco, CA, USA). The
slides were washed after each step. All the incubations and
washings were carried out at room temperature.
The specificity of the staining reaction was checked in a
negative control test, in which the primary antibody was
omitted from the procedure. Sections were lightly counter-
stained using Mayer’s haematoxylin. After dehydration and
clearing, the sections were mounted on DPX mountant
(neutral mounting medium) and examined under a Leitz
Diaplan microscope using a  40 objective.
2.6. Statistical analysis
All measurements were made in duplicate and results
are reported as meanF S.D. Statistical analysis was per-
formed with the Primer statistical program. Statistical
differences were calculated with one-way analysis of
variance (ANOVA) with a Student–Newman–Keuls fol-
low-up test.
Fig. 1. Cu, Zn and Fe contents (Ag/mg dry weight) in renal tissues of basal,
treated, and untreated LEC rats. The results are expressed as meanF S.D.
(n= 4 for the basal group; n= 13 for the untreated group; n= 13 for the Zn-
treated group). Different letters correspond to significant statistical
differences for P < 0.05.
Fig. 2. Metallothionein (MT) concentrations (Ag/mg total proteins) and its
oxidative status (%) in renal tissues of basal, treated, and untreated LEC
rats. (A) MT content measured by silver saturation method. The results are
expressed as meanF S.D. (n= 4 for the basal group; n= 13 for the untreated
group; n= 13 for the Zn-treated group). Different letters correspond to
significant statistical differences for P < 0.05. (B) Percentage of oxidized
MT (MTox) and reduced MT (MTrd).
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3.1. Concentrations of trace elements
Trace element concentrations in renal homogenate of
treated, untreated, and basal groups are shown in Fig. 1.
Zn concentrations were significantly higher in the treated
group than in both untreated and basal groups. In particular,
we observed that in the renal homogenate, Zn levels were
1.4- and 1.9-fold higher than both the untreated and basal
groups, respectively. Instead, Cu and Fe levels were signif-Fig. 3. Metallothionein (MT) isoforms expression (arbitrary units) in renal
tissues of basal, treated, and untreated LEC rats (A to B). (A) Samples of 10
Ag of total RNA hybridized with MT-1 and MT-2 oligonucleotide probes
and rehybridization with 18S rRNA oligonucleotide probe. (B) Comparison
between MT-1 and MT-2 isoforms expression. The results are expressed as
meanF S.D. (n= 4 for the basal group; n= 13 for the untreated group;
n = 13 for the Zn-treated group). The significance level observed is
**P< 0.001 when the two isoform values are compared.
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In fact, we found high levels of Cu and Fe concentrations in
the kidneys of the untreated group (2257.8F 564.1 and
360.4F 77.5 Ag/g dry weight, respectively), as expected. It
is well known that renal Cu concentrations increase notably
with age in LEC rats and are an important factor contrib-
uting to liver injury in these rats [33]. Moreover, in the
kidneys, Fe concentration in the treated group was similar to
that in the basal one.
3.2. Quantification and expression of MT
The supernatant MT concentrations and MT-1 and MT-2
isoform expressions in the kidneys of treated, untreated, and
basal groups are shown in Figs. 2 and 3.
The renal MT concentrations in the treated group were
3.3-fold higher than in the basal one, whereas no differences
were observed between treated and untreated group (Fig.
2A). Furthermore, the percent of MTox in the untreated
group was higher than that in the basal and treated ones. It
was about 49%, whereas the basal group expressed 30% and
treated group 8% of MTox (Fig. 2B).
To study the induction of MT-1 and MT-2 isoforms by
Zn treatment and Cu accumulation, Northen blot analyses
were performed using total RNA from treated, untreated,
and basal LEC rat kidneys. An 18S-RNA probe was used toFig. 4. Localization of cell death and MTs in LEC rat kidneys (A to F). Immun
untreated (C) groups. Localization of apoptotic cells (arrows) using Mab against
 40 objective (A to C);  63 objective (D to F).normalize RNA loading (Fig. 3A–B). The figure shows that
MT-1 mRNA was very highly induced following Zn treat-
ment. Quantification of the mRNA indicates that its level in
the treated group was significantly higher (1.3- and 5.4-fold,
respectively) than both the untreated and basal ones. More-
over, the level of MT-2 mRNA in the untreated group was
significantly higher (5.1-fold) than the basal group and
about 1.2-fold higher than the treated one. Moreover, by
comparing the two isoforms, it is clear that the induction of
MT-1 mRNA is higher than that of MT-2 mRNA after Zn
treatment (Fig. 3B).
3.3. Immunohistochemical localization of MT
To probe the effect of Zn treatment and Cu accumulation
on MT induction further, we investigated the immunohisto-
chemical distribution of MT in LEC rat kidneys.
In the kidneys of basal rats, the staining was weaker than
in both the treated and untreated rats and it was observed in
the nuclei of some of epithelial cells of proximal convoluted
tubules near the glomeruli (Fig. 4A). In contrast, strong MT-
positive staining was seen in the cytoplasm and in the nuclei
of both treated and untreated rat cells (Fig. 4B and C).
Intense immunostaining for MT appeared in the cortex of
proximal convoluted tubules and of distal tubules. We also
estimated that there was no appreciable differences in theodetection of MTs (arrows) in renal tissues of basal (A), treated (B), and
ssDNA in renal tissues of basal (D), treated (E), and untreated (F) groups.
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sections of both treated and untreated rats.
3.4. Detection of apoptotic cells
It is well known that LEC rats show an increase in
oxygen reactive species at 3–4 months [34]. On this basis,
we investigated the effect of metal interactions in relation to
apoptotic events caused by oxidative processes.
At confocal observation, the fluorescent staining with
Mab against ssDNA revealed higher scattered apoptotic
renal cells in untreated tissue sections compared to both
treated and basal ones. Untreated group sections showed a
high fluorescence signal that highlighted the nuclei diffusely
and more intensely (Fig. 4F). In contrast, the intensity and
quantity of fluorescence decreased in both the treated groups
and was absent in the basal one (Fig. 4E and D).
To confirm the specificity of Mab F7-26 binding to
ssDNA, sections heated in formamide were treated with
S1 nuclease (Gibco, Life Technologies, Italy, code 18001-
016) to digest DNA in single stranded conformation. This
treatment completely eliminated the subset of intensely
fluorescent apoptotic cells in all sections considered (data
not shown).4. Discussion
In this work, we performed a study aimed at analysing
the effects of 60-day treatment with Zn acetate on MT and
metal content (Zn, Cu and Fe), evaluating the levels of both
MT-1 and MT-2 mRNAs and also determining the distribu-
tion of MTs and apoptotic cells in LEC rat kidneys, an
animal model of WD.
Renal accumulation of heavy metals in LEC rats has
been reported by many authors [35,36]. The increased Cu
levels in the kidneys are considered to result from the
release of hepatic Cu from severely damaged hepatocytes.
The hepatic damage caused elevated Cu levels in both
erythrocytes and plasma of LEC rats (age 16F 4 weeks)
[33] and a drop of hepatic Cu levels after onset of jaundice
[37,38]. However, none of the authors have investigated the
antioxidant effect of Zn supplementation in these rats in
relation to apoptotic processes, MT gene expression, and its
localization in the kidneys. The role of Zn in protecting
biological structures from an excess of heavy metals ions
may be due to several factors such as the maintaining of an
adequate level of MTs, which are also free radical scav-
engers [27]. Moreover, Zn has multiple implications in
cellular metabolism, including cell death by apoptosis.
Several studies have demonstrated that Zn exposure can
block apoptosis in many cases [39,40]. Cohen et al. [41]
observed that Zn blocked the transition from the morpho-
logical stage in which the chromatin is condensed around
the periphery to that stage. The influence of Zn on apoptosis
is a well-known phenomenon. In both in vitro and in vivomodels, Zn supplementation prevents apoptosis induced by
a variety of agents [42,43]. One anti-apoptotic mechanism
of Zn is its capacity to minimize oxidative damage to
cellular organelles, thereby suppressing major signalling
pathways leading to caspase activation and apoptosis [44].
However, if Zn is known to protect from oxidative stress-
induced DNA damage [45,46], its mode of action remains
partly unknown. One hypothesis is competition for Fe or Cu
binding sites [47], a new insight has come from MT, which
can protect efficiently against H2O2-induced DNA damage
[48]. In this context, we investigated the effect of compe-
tition between metals in relation to apoptotic processes in
LEC rat kidneys. We used an immunocytochemical assay
that is not influenced by DNA breaks but reflects changes in
condensed chromatin, such as damage DNA–histone inter-
actions, and makes the specific identification of the apopto-
tic cells possible [49]. In our sections, we observed high
bright fluorescence in untreated tissue heated in the presence
of formamide and stained with the anti-ssDNA Mab. The
high fluorescence stain is a clear sign of renal dysfunction
induced by Cu. We believe, as also reported by Nomiyama
et al. [3], that active free Cu, which may be produced by the
degradation of Cu-MT in the acid environment of vesicles of
the tubular cells, could enhance the formation of reactive
oxygen species and increase cellular damage depressing the
membrane function of the proximal tubular cells. In partic-
ular, hydroxyl radicals were produced when cupric ions
were present in excess to replace all Zn bound to MT, and
then to oxidize all sulfhydryl groups in MT. Our results
show that the percentage of MTox in the untreated group
was about 49%, whereas the treated group showed 8%
MTox. In this same experiment, we also observed an
increase in MTox in both intestine and liver (about 40%
and 49%, respectively) tissues of the untreated group
(unpublished data). The presence of Cu-MT, as pro-oxidant,
and, in particular, MTox in elevated percentages can be
considered an index of oxidative stress resulting in cell
death [4,50]. In fact, MTox is not able to bind metals, so it
does not perform a ‘‘scavenger’’ function. On the contrary,
we observed a low fluorescent stain in both treated and basal
tissue with respect to the untreated one. We suppose that the
protective effect of Zn is also attributed to its capacity to
inhibit the formation of the tight face-to-face packaging of
nucleosomes, which might be related to the increase in the
amount of the unacetylated forms of histones H3 and H4
occurring in the course of condensation [51]. Moreover, Zn
is also an effective inducer of MT synthesis and binds avidly
to the protein; thus, one untested hypothesis is that the anti-
apoptotic effects of this metal may be related to MT. The
role of MT in apoptosis has been aggressively investigated
and the vast majority of studies shows that MT plays a
protective role with respect to apoptosis [52]. The basis of
these results is likely to be due to direct interaction of
apoptosis-inducing agents (e.g. metals) with the MT protein
that really lowers the free concentration of the apoptotic
agent.
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creases tissue Zn and MT content in LEC rat kidneys. In
particular, the immunohistochemical analyses show that in
the treated and untreated groups, there is an overall distri-
bution of MT which is mainly localized in the cytoplasm
and nuclei of both proximal and distal tubules, whereas in
the basal group staining is much less marked. The signifi-
cance of the presence of MT in nucleus of the renal cell may
be to protect the cell from DNA damage and apoptosis, and
also to regulate gene expression during certain stages of the
cell cycle. The metals which bind to MT can also bind to
histones, nucleolar RNA and nuclear acidic proteins and, as
indicated by our data, may modify MT gene expression. In
particular, treatment of mammalian cells with Zn in vivo
promotes rapid nuclear translocation of MTF-1 [53,54] and
causes a dramatic increase in MTF-1 DNA-binding activity
measured in vitro [55] concomitant with the occupancy of
MREs in the MT-1 promoter in vivo and the activation of
MT-1 gene expression [56]. Moreover, chromatin structure
has been shown to play an important role in MT-1 gene
expression. DNA methylation and histone acetylation have
been suggested in MT-1 gene silencing and reactivation in
mouse lymphosarcoma cells, respectively [57,58]. Further-
more, histone deacetylase inhibitors can increase heavy
metal-induced MT-1 gene expression [59]. From this point
of view, we postulated that the overexpression of MT-1 in
treated group was probably related not only to multiple
binding factors but also to the changes in chromatin struc-
ture and, as a consequence, to increased protection against
Cu and Fe toxicity and the harmful effects of oxidative
stress. We also hypothesized that the relationship between
MT-1 and MT-2 is highly metal- and tissue-dependent. In
our earlier paper [23], from the same experimental condi-
tions, we found no difference in MT-1 and MT-2 mRNA
levels in LEC rat liver. The inducers Cu and Zn were
selected because they both principally target the liver and
kidneys, but they also have a widely different efficacy of
MT induction and may activate gene expression through
different mechanisms. Since this is the first experiment in
which the relationship between these two isoforms in LEC
rat kidneys has been discussed, further studies to investigate
MT mRNA would be helpful in clarifying the effect of
metals on transcription processes, especially in genetic
disorders.
By virtue of the similarities in coordination chemistry, Zn
could also exert a direct antioxidant action by occupying Fe
or Cu binding sites in proteins and DNA [60,61]. It is well
known that Cu and Fe can participate in electron transfer
reactions with the consequent production of oxidant species
capable of oxidizing cell components. The competition of
Zn for Fe binding sites is particularly relevant taking in
account that Zn deficiency facilitates intracellular Fe accu-
mulation [51]. Our results show that treatment with zinc
acetate decreases Cu and Fe concentrations in renal homog-
enate. This reduction is probably accomplished by decreas-
ing the intestinal absorption of these metals. In a paperpublished by Cousins and McMahon [62], it is stated that
the Fe transporter Nramp 2 also exhibits Zn transport
capabilities. We suppose that in the presence of large
amounts of Zn, this transporter might bind more Zn than
Fe, causing a decrease in Fe content in tissues, but this
hypothesis must be supported by experiments on Fe trans-
porters and on interactions between Fe and Zn on these
specific binding sites. It is well known that Zn is thought to
be a more potent inducer of MT than Cu; however, MT has
much higher affinity for Cu than Zn, resulting in Cu
sequestration within enterocytes [63,64]. The complexation
of Cu prevents its serosal transfer, resulting in a decrease in
serum Cu levels and its excretion into the feces along with
intestinal cells [59]. Condomina et al. [65], in a kinetic Zn
transport study, observed that Cu, in elevated concentra-
tions, shows a different profile of influx inhibition of Zn
across the brush border membrane in three sectors of the
small intestine (proximal, mid and distal). Probably more
than one transporter is implicated in Zn uptake and there is
not a well-defined preferential site for the cation transport.
Furthermore, it is possible that the Cu intestinal uptake
could be inhibited by the presence of Zn in the lumen
content. We also postulated that Zn, at high doses, might
interact with Cu for the ligand sites on MT, as suggested by
our previous reports [31], decreasing metal content in renal
cells. The present work indicates the possible antioxidant
properties of Zn in relation to MT gene expression and
apoptotic processes in LEC rat kidneys, trying to clarify the
action mechanism of this essential metal, and thus, the
necessity of improving the study of MT in human WD is
strongly suggested. In this context, future experiments will
be performed in order to study the direct action mechanism
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